SCHEMBL9656369

SCHEMBL9656369

CCCCOC(=O)Oc1cc(Oc2ccccc2)c(OC(=O)OCCCC)c2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.45
KMT2A Q03164 2/20 0.45
LMNA P02545 2/20 0.45
HPGD P15428 1/20 0.45
KLK7 P49862 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ELANE P08246 6/20 0.44
MAPT P10636 2/20 0.42
KDM4E B2RXH2 2/20 0.42
LTA4H P09960 2/20 0.41
POLB P06746 1/20 0.40
ATM Q13315 1/20 0.40
TSHR P16473 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 1/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9657610 0.95 LMNA (0.42) L3MBTL1KMT2ALMNAHPGDKLK7
SCHEMBL9656394 0.93 LMNA (0.40) L3MBTL1KMT2ALMNAHPGDKLK7
SCHEMBL9658382 0.86 ELANE (0.47) L3MBTL1KMT2ALMNASMN1; SMN2ELANE
SCHEMBL9657137 0.85 ELANE (0.46) L3MBTL1LMNAHPGDSMN1; SMN2ELANE
SCHEMBL9656624 0.85 ELANE (0.46) L3MBTL1KMT2ALMNAHPGDKLK7
SCHEMBL9654727 0.85 LTA4H (0.47) L3MBTL1KMT2ALMNAHPGDKLK7
SCHEMBL9654930 0.85 L3MBTL1 (0.36) L3MBTL1KMT2ALMNAHPGDKLK7
SCHEMBL23271994 0.83 ELANE (0.48) L3MBTL1KMT2ALMNAHPGDKLK7
SCHEMBL23271745 0.83 HTT (0.56) L3MBTL1KMT2ALMNAHPGDKLK7
SCHEMBL9660321 0.83 SLC2A1 (0.46) L3MBTL1KMT2ALMNASMN1; SMN2ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed